Abnormal ligand binding and reversible ring hydrogenation in the reaction of imidazolium salts with IrH5(PPh3)(2)

• Published in: Journal of the American Chemical Society Vol. 124; no. 35; pp. 10473 - 10481
• Main Authors: Grundemann, S, Kovacevic, A, Albrecht, M, Faller, JW, Crabtree, RH
• Format: Journal Article
• Language: English
• Published: WASHINGTON Amer Chemical Soc 04.09.2002
• Subjects: Chemistry; Chemistry, Multidisciplinary; Physical Sciences; Science & Technology; TRANSITION-METAL-COMPLEXES; IRIDIUM; PALLADIUM COMPLEXES; HETEROCYCLIC CARBENE COMPLEXES; HOMOGENEOUS CATALYSIS; OXIDATIVE ADDITION; IONIC LIQUIDS; OLEFIN; NICKEL(II); EFFICIENT CATALYSTS
• ISSN: 0002-7863; 1520-5126
• DOI: 10.1021/ja026735g

We show that imidazolium salts do not always give normal or even aromatic carbenes on metalation, and the chemistry of these ligands can be much more complicated than previously thought. N,N'-disubstituted imidazolium salts of type [(2-py)(CH2)(n)(C3H3N2)R]BF4 react with IrH5(PPh3)(2) to give N,C-chelated products (n = 0, 1; 2-py = 2-pyridyl; C(3)H(3)N2 = imidazolium; R = mesityl, n-butyl, i-propyl, methyl). Depending on the circumstances, three types of kinetic products can be formed: in one, the imidazole metalation site is the normal C2 as expected; in another, the metalation occurs at the abnormal C4 site; and in the third, C4 metalation is accompanied by hydrogenation of the imidazolium ring. The bonding mode is confirmed by structural studies, and spectroscopic criteria can also distinguish the cases. Initial hydrogen transfer can take place from the metal to the carbene to give the imidazolium ring hydrogenation product, as shown by isotope labeling; this hydrogen transfer proves reversible on reflux when the abnormal aromatic carbene is obtained as final product. Care may therefore be needed in the future in verifying the structure(s) formed in cases where a catalyst is generated in situ from imidazolium salt and metal precursor.